GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.03.17	GlaxoSmithKline Reports MUSCA Study Results On Nucala (RTTNews)
23.02.17	GlaxoSmithKline Reports Positive Resultsfrom Relvar Ellipta Lung Function Study (RTTNews)
16.02.17	How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Pacira Pharma, and Supernus Pharma (PR Newswire)
14.02.17	GSK: ViiV Healthcare Shows Positive Study Results For Two-drug Regimen For HIV (RTTNews)
20.12.16	Drug Makers Stocks under Scanner -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline (PR Newswire)
20.12.16	GSK: ViiV Reports Positive Trial Results Of Two-drug HIV Treatment Regimen (RTTNews)
19.12.16	Glaxo Begins Phase III Study Of Triple Combination Therapy In Asthma Patients (RTTNews)
02.12.16	GSK Files Regulatory Submission In EU For Triple Combination Therapy On COPD (RTTNews)
02.12.16	GSK & Innoviva Announce Approval Of Relvar Ellipta In Japan For COPD (RTTNews)
25.11.16	GSK Announces EU Regulatory Submission Of Shingles Candidate Vaccine (RTTNews)
23.11.16	GSK : Mepolizumab Phase Lll Study Meets Co-primary Endpoints,secondary Endpoints (RTTNews)
21.11.16	GSK Announces FDA Approval Of Expanded Age Indication For Influenza Vaccine (RTTNews)
21.11.16	GSK Files For Triple Combination Therapy FF/UMEC/VI For Patients With COPD (RTTNews)
26.10.16	GSK Q3 Profit Rises, Sales Up 8% CER; Affirms 2016 Core EPS Growth Guidance (RTTNews)
24.10.16	GSK Submits BLA For Its Candidate Shingles Vaccine, Shingrix - Quick Facts (RTTNews)
29.09.16	GlaxoSmithKline Plans To Sell Remaining Holding In Aspen (RTTNews)
23.09.16	GSK Announces U.S. Regulatory Submission For Sirukumab In Rheumatoid Arthritis (RTTNews)
20.09.16	GlaxoSmithKline: Emma Walmsley To Succeed Andrew Witty As CEO In March 2017 (RTTNews)
12.09.16	GSK Reports EU Regulatory Submission For Sirukumab In Rheumatoid Arthritis (RTTNews)
05.09.16	GlaxoSmithKline Announces Positive Results From COPD Salford Lung Study (RTTNews)
16.08.16	ViiV Begins Phase III Programme To Evaluate Two-drug Regimen For HIV-1 Treatment (RTTNews)
01.08.16	GSK & Verily Life To Jointly Form New Company To Develop Bioelectronic Medicines (RTTNews)
18.07.16	ARIA Study Shows Efficacy Of Triumeq For Treatment-naïve Women Living With HIV (RTTNews)
21.06.16	GSK FULFILS Goals, CDXC Sinks On Short Seller Report, LPTN Up On Defense Grant (RTTNews)
20.06.16	GSK: FULFIL Study Meets Two Co-primary Endpoints - Quick Facts (RTTNews)
08.06.16	GSK' Phase III Sirukumab Study Meets Co-primary Endpoints In Patients With RA (RTTNews)
01.06.16	Regulus Therapeutics Expands Clinical Trial Collaboration With GSK (RTTNews)
24.05.16	Glaxo: Relvar Ellipta Achieves Superiority Over Usual Care In Patients With COPD (RTTNews)
18.05.16	Novartis To Split Pharma Unit Into Two (RTTNews)
27.04.16	GlaxoSmithKline Q1 Pretax Profit Declines; Group Sales Up 6% CER Pro-forma (RTTNews)
18.04.16	MorphoSys: GSK Starts Phase 2 Study With GSK3196165 In Hand Osteoarthritis (RTTNews)
01.04.16	GSK Gets Positive CHMP Opinion For Strimvelis To Treat Rare Disease ADA-SCID (RTTNews)
29.03.16	GSK: Nucala Receives Approval In Japan For Treatment Of Bronchial Asthma (RTTNews)
17.03.16	GlaxoSmithKline CEO Andrew Witty To Retire In March 2017 (RTTNews)
08.03.16	Genmab Issues Update On Ofatumumab; To Discontinue Study In Pemphigus Vulgaris (RTTNews)
02.03.16	Weak Spot Identified In Severe Form Of Childhood Leukemia (RTTNews)
08.02.16	Valneva Signs R&D Collaboration With GlaxoSmithKline For The EB66 Cell Line (RTTNews)
03.02.16	GlaxoSmithKline 2015 Pro-forma Core Operating Profit Down 2.7%; Turnover Up 1% (RTTNews)
02.02.16	Adaptimmune, GSK Broaden Strategic Immunotherapy Collaboration - Quick Facts (RTTNews)
02.02.16	Medicxi Ventures Launches As Independent Venture Capital Firm (RTTNews)
21.12.15	GlaxoSmithKline Completes Divestment Of Its Rights To Ofatumumab - Quick Facts (RTTNews)
16.12.15	GlaxoSmithKline Gets Positive Results From Sirukumab PhIII Programme (RTTNews)
15.12.15	Amgen Reacquires Rights To Prolia, XGEVA And Vectibix From GSK In 48 Countries (RTTNews)
02.12.15	GSK Says Nucala Available In U.S. For Sub-group Of Patients With Severe Asthma (RTTNews)
05.11.15	FDA Approves GSK's Nucala To Treat Severe Asthma (RTTNews)
04.11.15	BIOD Plans Overhaul, Stellar To Uplist, AERI To File NDA, Time To Follow NXTM (RTTNews)
03.11.15	GSK Plans 20 New Drugs By End Of Decade (RTTNews)
03.11.15	ViiV Healthcare Says Phase IIb Study LATTE 2 Meets Primary Endpoint (RTTNews)
03.11.15	GSK, Merck To Study Immunotherapy Combination As Potential Cancer Treatment (RTTNews)
29.10.15	Pfizer Reports Multi-year Collaboration With GSK (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft